ArticleProceedings of the National Academy of Sciences of the United States of America2016

Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.

Geraldine Harriman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.